A DESCRIPTIVE ANALYSIS OF TONGUE CARCINOMA: EPIDEMIOLOGY AND THERAPEUTIC OUTCOMES
Main Article Content
Keywords
Tongue carcinoma, oral squamous cell carcinoma, epidemiology, risk factors, TNM staging, treatment outcomes
Abstract
Background: Carcinoma of the tongue is a common and aggressive malignancy of the oral cavity, predominantly arising as squamous cell carcinoma (SCC). It is associated with high morbidity due to functional impairment of speech, swallowing, and aesthetics. Risk factors include tobacco use, betel quid chewing, alcohol consumption, and human papillomavirus (HPV) infection. Despite advances in treatment, late-stage presentation remains a major challenge in improving survival outcomes.
Objective: To describe the epidemiology, risk factors, clinical presentation, staging, and therapeutic outcomes of patients with carcinoma of the tongue in a tertiary care hospital setting.
Methods: This observational cross-sectional study included 60 patients with histopathologically confirmed tongue carcinoma, conducted over 12 months in the Departments of Oral & Maxillofacial Surgery and ENT. Patients aged ≥18 years with primary tongue SCC were enrolled, while those with recurrent disease, metastatic lesions from other sites, or prior chemo-radiotherapy were excluded. Data on demographics, risk factors, clinical features, TNM staging, and treatment modalities were collected using a structured proforma and analyzed using SPSS version 25. Descriptive statistics were calculated as frequencies and percentages.
Results: Among 60 patients, 70% were male and 53.3% were aged 41–60 years. The lateral border of the tongue was the most commonly affected site (63.3%). Tobacco use was the predominant risk factor (66.7%), followed by smokeless tobacco (58.3%) and betel quid/areca nut chewing (50%). Clinically, non-healing ulcers (75%) and pain (63.3%) were the most frequent presentations, with cervical lymphadenopathy observed in 50% of patients. Most cases presented at advanced stages, with Stage III and IV accounting for 61.6% of patients. Treatment primarily involved surgery with adjuvant radiotherapy (41.7%), while early-stage disease was managed with surgery alone (30%).
Conclusion: Tongue carcinoma predominantly affects middle-aged males and is strongly associated with tobacco, betel quid, and alcohol use. Late-stage presentation is common, contributing to increased morbidity and complex treatment requirements. Implementation of early detection programs, public awareness campaigns, and lifestyle modification initiatives is essential to reduce disease burden and improve clinical outcomes.
References
2. ller S. Update from the 4th edition of the World Health Organization of head and neck tumours: tumours of the oral cavity and mobile tongue. Head and neck pathology. 2017 Mar;11(1):33-40.
3. Zhang SZ, Xie L, Shang ZJ. Burden of oral cancer on the 10 most populous countries from 1990 to 2019: estimates from the global burden of disease study 2019. International journal of environmental research and public health. 2022 Jan 13;19(2):875.
4. Gunjal S, Pateel DG, Yang YH, Doss JG, Bilal S, Maling TH, Mehrotra R, Cheong SC, Zain RB. An overview on betel quid and areca nut practice and control in selected Asian and South East Asian countries. Substance Use & Misuse. 2020 Jun 1;55(9):1533-44.
5. Lieu PK, Chong MS, Seshadari R. The impact of swallowing disorders in the elderly. Annals-Academy of Medicine Singapore. 2001 Mar 1;30(2):148-54.
6. Piagkou M, Demesticha T, Chrissanthou I, Lappas D, Piagkos G, Mazarakis A, Skandalakis P. Tongue anatomy and oral cancer: The route of metastasis. Tongue: Anatomy, Kinematics and Diseases; Nova Biomedical: Runcorn, UK. 2012:209-20.
7. Mohideen K, Krithika C, Jeddy N, Bharathi R, Thayumanavan B, Sankari SL. Meta-analysis on risk factors of squamous cell carcinoma of the tongue in young adults. Journal of Oral and Maxillofacial Pathology. 2019 Sep 1;23(3):450-7.
8. Karatas OF, Oner M, Abay A, Diyapoglu A. MicroRNAs in human tongue squamous cell carcinoma: From pathogenesis to therapeutic implications. Oral oncology. 2017 Apr 1;67:124-30.
9. Noor AE, Ramanarayana B. Relationship of smokeless tobacco uses in the perspective of oral cancer: A global burden. Oral oncology reports. 2024 Jun 1;10:100516.
10. Mello FW, Melo G, Pasetto JJ, Silva CA, Warnakulasuriya S, Rivero ER. The synergistic effect of tobacco and alcohol consumption on oral squamous cell carcinoma: a systematic review and meta-analysis. Clinical oral investigations. 2019 Jul 1;23(7):2849-59.
11. Petrelli F, De Santi G, Rampulla V, Ghidini A, Mercurio P, Mariani M, Manara M, Rausa E, Lonati V, Viti M, Luciani A. Human papillomavirus (HPV) types 16 and 18 infection and esophageal squamous cell carcinoma: a systematic review and meta-analysis. Journal of Cancer Research and Clinical Oncology. 2021 Oct;147(10):3011-23.
12. Kumari P, Debta P, Dixit A. Oral potentially malignant disorders: etiology, pathogenesis, and transformation into oral cancer. Frontiers in pharmacology. 2022 Apr 20;13:825266.
13. Ramanathan A, Ismail SM, De Silva HL. Non-healing Ulcer in the Right Lateral Surface of the Tongue: Oral Cancer. InClinicopathological Correlation of Oral Diseases 2023 Jul 22 (pp. 283-298). Cham: Springer International Publishing.
14. De Berardinis R, Tagliabue M, Belloni P, Gandini S, Scaglione D, Maffini F, Margherini S, Riccio S, Giugliano G, Bruschini R, Chu F. Tongue cancer treatment and oncological outcomes: The role of glossectomy classification. Surgical Oncology. 2022 Jun 1;42:101751.
15. Sebastian GA. A Descriptive Study of Patient Profiles, Clinicopathological Characteristics, and Treatment Outcomes of Patients with Oral Tongue Squamous Cell Carcinoma Treated with Glossectomy at the University of Washington Medical Center. University of Washington; 2021.

